Breast disease targets and uses thereof
AssigneeCelera Corporation
InventorsJenny Heidbrink, Steve Ruben, Charles E. Birse, Tao He
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with breast. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in breast diseases (BCAT) and antibodies binds to BCAT. The present invention provides that BCAT is used as targets for screening agents that modulates the BCAT activities. Further the present invention provides methods for treating diseases associated with breast.
Claims3
A method of diagnosing breast cancer in an individual, the method comprising detecting an elevated level of NPC2 protein in a breast sample from the individual relative to a control NPC2 protein level of a non-cancerous breast sample, wherein the elevated level of NPC2 protein indicates that the individual has breast cancer, and wherein the amino acid sequence of the NPC2 protein comprises SEQ ID NO:1798.
Dependencies are inferred from the claim text.